Found: 57
Select item for more details and to access through your institution.
Metastatic Malignant Melanoma From an Unknown Primary Presenting as a Large Axillary Mass.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 7, p. 763
- By:
- Publication type:
- Article
Solute Transport in Engineered Living Materials Using Bone‐Inspired Microscale Channel Networks.
- Published in:
- Advanced Engineering Materials, 2023, v. 25, n. 24, p. 1, doi. 10.1002/adem.202301032
- By:
- Publication type:
- Article
Solute Transport in Engineered Living Materials Using Bone‐Inspired Microscale Channel Networks.
- Published in:
- Advanced Engineering Materials, 2023, v. 25, n. 24, p. 1, doi. 10.1002/adem.202301032
- By:
- Publication type:
- Article
Small Molecule Inhibitors of the Hedgehog Pathway in the Treatment of Basal Cell Carcinoma of the Skin.
- Published in:
- American Journal of Clinical Dermatology, 2018, v. 19, n. 2, p. 195, doi. 10.1007/s40257-017-0319-4
- By:
- Publication type:
- Article
Twist1 Inactivation in Dmp1-Expressing Cells Increases Bone Mass but Does Not Affect the Anabolic Response to Sclerostin Neutralization.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 18, p. 4427, doi. 10.3390/ijms20184427
- By:
- Publication type:
- Article
Adjuvant Therapy for Stage III Melanoma Without Immediate Completion Lymph Node Dissection.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 2, p. 806, doi. 10.1245/s10434-021-10775-8
- By:
- Publication type:
- Article
ASO Visual Abstract: Adjuvant Therapy for Stage III Melanoma without Immediate Completion Lymph Node Dissection.
- Published in:
- 2021
- By:
- Publication type:
- Abstract
Immunosuppressive Dendritic and Regulatory T Cells are Upregulated in Melanoma Patients.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2007, v. 14, n. 10, p. 2854, doi. 10.1245/s10434-007-9488-3
- By:
- Publication type:
- Article
Targeting wild-type TP53 using AMG 232 in combination with MAPK inhibition in Metastatic Melanoma; a phase 1 study.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 5, p. 1051, doi. 10.1007/s10637-022-01253-3
- By:
- Publication type:
- Article
A phase 2 study of ontuxizumab, a monoclonal antibody targeting endosialin, in metastatic melanoma.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 1, p. 103, doi. 10.1007/s10637-017-0530-4
- By:
- Publication type:
- Article
Effects of Sonidegib Following Dose Reduction and Treatment Interruption in Patients with Advanced Basal Cell Carcinoma During 42-Month BOLT Trial.
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 6, p. 2225, doi. 10.1007/s13555-021-00619-4
- By:
- Publication type:
- Article
Key Clinical Adverse Events in Patients with Advanced Basal Cell Carcinoma Treated with Sonidegib or Vismodegib: A Post Hoc Analysis.
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 5, p. 1839, doi. 10.1007/s13555-021-00588-8
- By:
- Publication type:
- Article
Brief overview: cemiplimab for the treatment of advanced basal cell carcinoma: PD-1 strikes again.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359211066147
- By:
- Publication type:
- Article
Brief overview: cemiplimab for the treatment of advanced basal cell carcinoma: PD-1 strikes again.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359211066147
- By:
- Publication type:
- Article
Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local control.
- Published in:
- 2011
- By:
- Publication type:
- journal article
The Absent-Minded Professor: An Unusual Complication of Melanoma.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 14, p. 1609
- By:
- Publication type:
- Article
A Case of Merkel Cell Carcinoma.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 3, p. 322
- By:
- Publication type:
- Article
Early objective response to avelumab treatment is associated with improved overall survival in patients with metastatic Merkel cell carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 4, p. 609, doi. 10.1007/s00262-018-02295-4
- By:
- Publication type:
- Article
Gabapentin Disrupts Binding of Perlecan to the α 2 δ 1 Voltage Sensitive Calcium Channel Subunit and Impairs Skeletal Mechanosensation.
- Published in:
- Biomolecules (2218-273X), 2022, v. 12, n. 12, p. 1857, doi. 10.3390/biom12121857
- By:
- Publication type:
- Article
Development of vitiligo during melanoma treatment with a novel survivin inhibitor: a case report and review of the literature.
- Published in:
- International Journal of Dermatology, 2009, v. 48, n. 4, p. 426, doi. 10.1111/j.1365-4632.2009.03987.x
- By:
- Publication type:
- Article
A Phase II Study of Glembatumumab Vedotin for Metastatic Uveal Melanoma.
- Published in:
- Cancers, 2020, v. 12, n. 8, p. 2270, doi. 10.3390/cancers12082270
- By:
- Publication type:
- Article
Pre-Treatment Mutational and Transcriptomic Landscape of Responding Metastatic Melanoma Patients to Anti-PD1 Immunotherapy.
- Published in:
- Cancers, 2020, v. 12, n. 7, p. 1943, doi. 10.3390/cancers12071943
- By:
- Publication type:
- Article
Updates on the treatment of advanced Melonoma.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Updates on the Treatment of Advanced Melanoma.
- Published in:
- Journal of Clinical & Aesthetic Dermatology, 2012, p. 18
- By:
- Publication type:
- Article
Post or perish? Social media strategies for disseminating orthopedic research.
- Published in:
- Journal of Orthopaedic Research, 2023, v. 41, n. 8, p. 1643, doi. 10.1002/jor.25588
- By:
- Publication type:
- Article
The importance of diversity, equity, and inclusion in orthopedic research.
- Published in:
- Journal of Orthopaedic Research, 2020, v. 38, n. 8, p. 1661, doi. 10.1002/jor.24685
- By:
- Publication type:
- Article
A phase I dose-escalation, safety and pharmacokinetic study of the 2-methoxyestradiol analog ENMD-1198 administered orally to patients with advanced cancer.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 2, p. 340, doi. 10.1007/s10637-009-9383-9
- By:
- Publication type:
- Article
A multi-center phase II evaluation of the small molecule survivin suppressor YM155 in patients with unresectable stage III or IV melanoma.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 1, p. 161, doi. 10.1007/s10637-009-9333-6
- By:
- Publication type:
- Article
A phase II study of the heparanase inhibitor PI-88 in patients with advanced melanoma.
- Published in:
- Investigational New Drugs, 2008, v. 26, n. 1, p. 89, doi. 10.1007/s10637-007-9080-5
- By:
- Publication type:
- Article
A phase II open-label trial of apomine (SR-45023A) in patients with refractory melanoma.
- Published in:
- Investigational New Drugs, 2006, v. 24, n. 1, p. 89, doi. 10.1007/s10637-005-4544-y
- By:
- Publication type:
- Article
Health‐related quality of life in patients with metastatic basal cell carcinoma treated with cemiplimab: Analysis of a phase 2 trial.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 14, p. 1, doi. 10.1002/cam4.7360
- By:
- Publication type:
- Article
Safety and efficacy of the combination of nivolumab plus ipilimumab in patients with melanoma and asymptomatic or symptomatic brain metastases (CheckMate 204).
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 11, p. 1961, doi. 10.1093/neuonc/noab094
- By:
- Publication type:
- Article
Therapeutic options in cutaneous melanoma: latest developments.
- Published in:
- Therapeutic Advances in Medical Oncology, 2011, v. 3, n. 5, p. 245, doi. 10.1177/1758834011415308
- By:
- Publication type:
- Article
No Hasty Conclusions: Milton's Ante-Nicene Pneumatology.
- Published in:
- Milton Quarterly, 1977, v. 11, n. 4, p. 102, doi. 10.1111/j.1094-348X.1977.tb00019.x
- By:
- Publication type:
- Article
Side Population Cells from Human Melanoma Tumors Reveal Diverse Mechanisms for Chemoresistance.
- Published in:
- Journal of Investigative Dermatology, 2012, v. 132, n. 10, p. 2440, doi. 10.1038/jid.2012.161
- By:
- Publication type:
- Article
Impact of depth of response on survival in patients treated with cobimetinib ± vemurafenib: pooled analysis of BRIM-2, BRIM-3, BRIM-7 and coBRIM.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Impact of initial treatment and prognostic factors on postprogression survival in BRAF-mutated metastatic melanoma treated with dacarbazine or vemurafenib ± cobimetinib: a pooled analysis of four clinical trials.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A nomogram to predict node positivity in patients with thin melanomas helps inform shared patient decision making.
- Published in:
- Journal of Surgical Oncology, 2019, v. 120, n. 7, p. 1276, doi. 10.1002/jso.25720
- By:
- Publication type:
- Article
Long- and Medium-Term Financial Strategies on Equities Using Dynamic Bayesian Networks.
- Published in:
- AppliedMath, 2024, v. 4, n. 3, p. 843, doi. 10.3390/appliedmath4030045
- By:
- Publication type:
- Article
Long-term Follow-up and Survival of Patients Following a Recurrence of Melanoma After a Negative Sentinel Lymph Node Biopsy Result.
- Published in:
- JAMA Surgery, 2013, v. 148, n. 5, p. 456, doi. 10.1001/jamasurg.2013.1335
- By:
- Publication type:
- Article
Safety profile and pharmacokinetic analyses of the anti-CTLA4 antibody tremelimumab administered as a one hour infusion.
- Published in:
- Journal of Translational Medicine, 2012, v. 10, n. 1, p. 236, doi. 10.1186/1479-5876-10-236
- By:
- Publication type:
- Article
A phase I/II study of rovalpituzumab tesirine in delta-like 3—expressing advanced solid tumors.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00214-y
- By:
- Publication type:
- Article
Phase 2 Study of Cemiplimab in Patients with Locally Advanced Basal-Cell Carcinoma After Hedgehog Inhibitor Therapy: Long-Term Follow-Up.
- Published in:
- Journal of Oncology Navigation & Survivorship, 2022, v. 13, n. 11, p. 386
- By:
- Publication type:
- Article
Primary Analysis of Phase 2 Results for Cemiplimab in Patients with mBCC Who Progressed on or Were Intolerant to Hedgehog Inhibitors.
- Published in:
- Journal of Oncology Navigation & Survivorship, 2022, v. 13, n. 11, p. 387
- By:
- Publication type:
- Article
Immune checkpoint inhibitors and radiosurgery for newly diagnosed melanoma brain metastases.
- Published in:
- Journal of Neuro-Oncology, 2018, v. 140, n. 1, p. 55, doi. 10.1007/s11060-018-2930-5
- By:
- Publication type:
- Article
Metastatic melanoma in the breast: A report of 27 cases.
- Published in:
- Journal of Surgical Oncology, 2006, v. 94, n. 2, p. 101, doi. 10.1002/jso.20592
- By:
- Publication type:
- Article
The evolution of combined molecular targeted therapies to advance the therapeutic efficacy in melanoma: a highlight of vemurafenib and cobimetinib.
- Published in:
- OncoTargets & Therapy, 2016, v. 9, p. 3739, doi. 10.2147/OTT.S86774
- By:
- Publication type:
- Article
Lymphangiomatosis Masquerading as Metastatic Melanoma.
- Published in:
- American Surgeon, 2006, v. 72, n. 4, p. 367, doi. 10.1177/000313480607200420
- By:
- Publication type:
- Article
Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: a randomized clinical trial.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Effect of Selumetinib vs Chemotherapy on Progression-Free Survival in Uveal Melanoma.
- Published in:
- JAMA: Journal of the American Medical Association, 2014, v. 311, n. 23, p. 2397, doi. 10.1001/jama.2014.6096
- By:
- Publication type:
- Article